Quotient: Isabelle Buckle, Catherine Larue

Quotient announced the appointment of two new members to its board of directors to replace Sarah O'Connor and Thomas Bologna, who are stepping down. Isabelle Buckle is the executive VP of technology transfer and industrial partnership at the Institut Pasteur in Paris. She was previously the global VP of clinical mass spectrometry at Bruker Daltonics and CEO and chairman of InGen Biosciences. 

Catherine Larue is the director of external affairs at the Integrated Biobank of Luxemburg and formerly served as CEO at the biobank. She previously led a business unit at Bio-Rad Laboratories. Both Buckle and Larue will join the board on Sept. 1.